glycerol has been researched along with lactulose in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cassidy, D; Johnston, DG; Laker, MF; Møller, N; Petrany, G; Sheldon, WL | 1 |
| Feldstein, TJ | 1 |
| Bercoff, E; Capet, C; Chassagne, P; Denis, P; Doucet, J; Gloc, P; Jego, A; Trivalle, C | 1 |
| Abadias, M; Teixidó, N; Torres, R; Usall, J; Viñas, I | 1 |
| Ferchaud-Roucher, V; Krempf, M; Piloquet, H; Pouteau, E; Zaïr, Y | 1 |
| Clemente, A; Hernández-Hernández, O; Montañés, F; Moreno, FJ; Sanz, ML | 1 |
| Jalan, R; Jover-Cobos, M; Khetan, V | 1 |
| Sussman, NL | 1 |
| Alsahhar, JS; Rahimi, RS | 1 |
| Cheon, W; Jo, YI; Kim, YB; Ko, YK; Lee, JH; Lim, CH; Park, JH; Shin, WJ | 1 |
| Mahpour, NY; Pioppo-Phelan, L; Reja, M; Rustgi, VK; Tawadros, A | 1 |
| Dias, RF; Diniz, MML; Nobre, VA; Santos, BC | 1 |
4 review(s) available for glycerol and lactulose
| Article | Year |
|---|---|
Treatment of hyperammonemia in liver failure.
Topics: Ammonia; Brain; Glycerol; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Phenylbutyrates; Probiotics; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin | 2014 |
Treatment of Overt Hepatic Encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Arteriovenous Fistula; Dipeptides; Gastrointestinal Agents; Glycerol; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure; Malnutrition; Ornithine; Phenylbutyrates; Probiotics; Rifamycins; Rifaximin | 2015 |
Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
Topics: Amino Acids, Aromatic; Amino Acids, Branched-Chain; Ammonia; Dipeptides; Fecal Microbiota Transplantation; Frailty; Gastrointestinal Agents; Gastrointestinal Microbiome; Glycerol; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Ornithine; Phenylbutyrates; Polyethylene Glycols; Probiotics; Rifaximin; Trace Elements; Zinc | 2019 |
Pharmacologic Management of Hepatic Encephalopathy.
Topics: Acarbose; Amino Acids, Branched-Chain; Anti-Bacterial Agents; Dipeptides; Fecal Microbiota Transplantation; Flumazenil; GABA Modulators; Glycerol; Glycoside Hydrolase Inhibitors; Hepatic Encephalopathy; Humans; Lactulose; Laxatives; Phenylbutyrates; Probiotics; Rifaximin | 2020 |
3 trial(s) available for glycerol and lactulose
| Article | Year |
|---|---|
Effects of the somatostatin analogue SMS 201-995 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man.
Topics: 3-Hydroxybutyric Acid; 3-O-Methylglucose; Adult; Blood Glucose; Breath Tests; Dietary Carbohydrates; Dietary Fats; Fatty Acids, Nonesterified; Gastrointestinal Transit; Glycerol; Humans; Hydroxybutyrates; Insulin; Intestinal Absorption; Lactulose; Male; Methylglucosides; Octreotide; Time Factors; Triglycerides | 1988 |
Does treatment of constipation improve faecal incontinence in institutionalized elderly patients?
Topics: Aged; Aged, 80 and over; Cathartics; Constipation; Fecal Incontinence; Follow-Up Studies; Glycerol; Homes for the Aged; Humans; Institutionalization; Lactulose; Nursing Homes; Prospective Studies; Treatment Outcome | 2000 |
Colonic fermentation from lactulose inhibits lipolysis in overweight subjects.
Topics: Acetates; Administration, Oral; Colon; Diet Therapy; Fatty Acids, Nonesterified; Female; Fermentation; Glycerol; Humans; Lactulose; Lipolysis; Male; Metabolic Clearance Rate; Middle Aged; Obesity | 2005 |
6 other study(ies) available for glycerol and lactulose
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Carbohydrate and alcohol content of 200 oral liquid medications for use in patients receiving ketogenic diets.
Topics: Administration, Oral; Capsules; Chemistry, Pharmaceutical; Dietary Carbohydrates; Ethanol; Food, Formulated; Fructose; Glycerol; Humans; Ketosis; Lactulose; Seizures; Solutions; Sorbitol; Sucrose; Tablets | 1996 |
Liquid formulation of the biocontrol agent Candida sake by modifying water activity or adding protectants.
Topics: Candida; Carboxymethylcellulose Sodium; Colony Count, Microbial; Culture Media; Dextrins; Erythritol; Fructose; Glutamic Acid; Glycerol; Lactulose; Maltose; Malus; Penicillium; Polyethylene Glycols; Trehalose; Water | 2003 |
Characterization of galactooligosaccharides derived from lactulose.
Topics: Aspergillus; beta-Galactosidase; Chromatography, High Pressure Liquid; Disaccharides; Fungal Proteins; Galactose; Gas Chromatography-Mass Spectrometry; Glycerol; Kluyveromyces; Lactulose; Oligosaccharides; Prebiotics; Trisaccharides | 2011 |
Effects of early detection of peritoneal catheter migration on clinical outcomes: 15-years experiences from a single centre.
Topics: Administration, Oral; Adult; Aged; Cathartics; Catheters, Indwelling; Conservative Treatment; Early Diagnosis; Enema; Female; Foreign-Body Migration; Glycerol; Humans; Lactulose; Male; Middle Aged; Peritoneal Dialysis; Retrospective Studies; Time Factors; Treatment Outcome | 2020 |
Gastrointestinal dysmotility in a patient with advanced lung cancer: paraneoplastic or drug-induced?
Topics: Aged; Antiemetics; Carcinoma, Squamous Cell; Constipation; Gastrointestinal Agents; Gastrointestinal Diseases; Gastrointestinal Motility; Gastroparesis; Glycerol; Humans; Lactulose; Lung Neoplasms; Male; Metoclopramide; Morphine; Opioid-Induced Constipation; Palliative Care; Paraneoplastic Syndromes, Nervous System; Tramadol | 2021 |